Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Szardenings

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Gene|September 28, 1990
A phasmid optimised for protein design projects: pMAMPFM Szardenings, J Collins
European Journal of Biochemistry|March 15, 1992
Recombinant human retinoic acid receptor alpha. Binding of DNA and synthetic retinoids to the protein expressed in Escherichia coliS Keidel, E Rupp, M Szardenings
European Journal of Biochemistry|February 15, 1993
In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic-acid receptor alpha and recombinant-cellular retinoic-acid-binding protein IS Keidel, M Szardenings, W H Mueller
Journal of Biotechnology|August 31, 2001
Cosmix-plexing: a novel recombinatorial approach for evolutionary selection from combinatorial librariesJ Collins, N Horn, J Wadenbäck, et al.
Journal of Molecular Biology|June 20, 1992
Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type)H J Hecht, M Szardenings, J Collins, et al.
Journal of Molecular Biology|August 5, 1991
Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type)H J Hecht, M Szardenings, J Collins, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2020
Dupilumab-induced serum sickness-like reaction: an unusual adverse effect in a patient with atopic eczemaR Treudler, N Delaroque, M Puder, et al.
European Journal of Pharmacology|October 31, 1996
Alternative translation initiation codon for the human melanocortin MC3 receptor does not affect the ligand bindingH B Schiöth, R Muceniece, J E Wikberg, et al.
Protein Engineering|January 1, 1995
Highly effective protease inhibitors from variants of human pancreatic secretory trypsin inhibitor (hPSTI): an assessment of 3-D structure-based protein designM Szardenings, B Vasel, H J Hecht, et al.
Molecular Pharmacology|July 11, 1998
Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptidesH B Schiöth, P Yook, R Muceniece, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Gene|September 28, 1990
A phasmid optimised for protein design projects: pMAMPFM Szardenings, J Collins
European Journal of Biochemistry|March 15, 1992
Recombinant human retinoic acid receptor alpha. Binding of DNA and synthetic retinoids to the protein expressed in Escherichia coliS Keidel, E Rupp, M Szardenings
European Journal of Biochemistry|February 15, 1993
In vivo biological activity of retinoids partially correlates to their affinity to recombinant retinoic-acid receptor alpha and recombinant-cellular retinoic-acid-binding protein IS Keidel, M Szardenings, W H Mueller
Journal of Biotechnology|August 31, 2001
Cosmix-plexing: a novel recombinatorial approach for evolutionary selection from combinatorial librariesJ Collins, N Horn, J Wadenbäck, et al.
Journal of Molecular Biology|June 20, 1992
Three-dimensional structure of a recombinant variant of human pancreatic secretory trypsin inhibitor (Kazal type)H J Hecht, M Szardenings, J Collins, et al.
Journal of Molecular Biology|August 5, 1991
Three-dimensional structure of the complexes between bovine chymotrypsinogen A and two recombinant variants of human pancreatic secretory trypsin inhibitor (Kazal-type)H J Hecht, M Szardenings, J Collins, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 29, 2020
Dupilumab-induced serum sickness-like reaction: an unusual adverse effect in a patient with atopic eczemaR Treudler, N Delaroque, M Puder, et al.
European Journal of Pharmacology|October 31, 1996
Alternative translation initiation codon for the human melanocortin MC3 receptor does not affect the ligand bindingH B Schiöth, R Muceniece, J E Wikberg, et al.
Protein Engineering|January 1, 1995
Highly effective protease inhibitors from variants of human pancreatic secretory trypsin inhibitor (hPSTI): an assessment of 3-D structure-based protein designM Szardenings, B Vasel, H J Hecht, et al.
Molecular Pharmacology|July 11, 1998
Chimeric melanocortin MC1 and MC3 receptors: identification of domains participating in binding of melanocyte-stimulating hormone peptidesH B Schiöth, P Yook, R Muceniece, et al.
Pageof 2